ClinicalTrials.Veeva

Menu

Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Cardiac Arrhythmia

Treatments

Device: AleriTM sensors

Study type

Interventional

Funder types

Other

Identifiers

NCT04609683
20-01233

Details and patient eligibility

About

Subjects will be consented to wear the AleriTM sensor prior to, during, and after an Electrophysiology Procedure. During this time, the system will measure the following parameters from subjects: HR, temperature, saline volume/rate, urine production volume, USG, BPO. Data will be retrospectively analyzed to determine if the system effectively operates under these conditions, and can effectively monitor hydration levels of subjects compared to currently available methods.

Full description

Study subjects scheduled for an EP procedure who have signed an informed consent form (ICF) will be admitted to the study. Prior to the EP procedure (e.g. in a hospital room or operating room at NYU Medical Center), either an employee of NYU or Hydrostasis will place sensor on subject's bicep, forearm, or wrist, start the sensor and connect the sensor to mobile app to start data collection.

Enrollment

19 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with cardiac arrhythmias or other cardiac conditions that are scheduled for EP procedures.
  • Subject is over 18 years of age at the time of consenting
  • Subject and/or legally authorized representative is willing to undergo the informed consent process prior to enrollment in the study

Exclusion criteria

  • Pregnant subjects
  • Subjects who are participating in another clinical study that may affect the results of either study
  • Subjects who are unwilling or unable to wear the sensor for a period of up to 14 hours
  • Subjects who are considered by the principle investigator to be medically unsuitable for study participation

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

Hydrostasis group
Experimental group
Description:
50 study subjects scheduled for an EP procedure will have AleriTM sensors on subject's bicep, forearm, or wrist, to start data collection. Measurements will be made from the subject for a period of approximately 1 hours prior to the EP procedure. . Measurements will continue as patient is moved to the operating room. Once the EP procedure is complete, the subject will be transferred from the operating room to a hospital room, where they will stay overnight. Measurements will be made for 3-5hours post-operation.Detailed analysis will investigate how does AleriTM data correlate with known measures such as saline volume/rate, urine production volume, USG, Blood osmolality and body weight;
Treatment:
Device: AleriTM sensors

Trial contacts and locations

1

Loading...

Central trial contact

April Jacob; Lior Jankelson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems